Neuronetics, Inc. — Form 10-Q
Filed August 11, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 28/100
What the filing says
On May 28, 2026, shareholders approved the Neuronetics, Inc. 2026 Equity Incentive Plan, which succeeded the 2018 plan. The new plan reserves 5,780,542 shares (plus future returning shares and annual 4% increases through 2036) for stock awards to employees, directors, and consultants. No specific new awards, dollar amounts, or share grants were disclosed in this filing—it is the plan document itself, establishing the framework and rules for future equity compensation.
Why this rating
Equity plan adoption is routine corporate governance. Relative to $129M market cap, 5.8M authorized shares is material (assuming $20–30/share, ~$116–174M potential dilution), but no imminent issuance or concentration event disclosed. Boilerplate structural document.
See more from August 11, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.